SolGold PLC Announces Holdings in Company
LONDON, UK / ACCESSWIRE / May 5, 2021 / In accordance with the Disclosure and…
LONDON, UK / ACCESSWIRE / May 5, 2021 / In accordance with the Disclosure and…
EASTLEIGH, UK / ACCESSWIRE / May 5, 2021 / i3 Energy plc (AIM:I3E) (TSX:ITE), an…
Hankook is once again the exclusive tyre partner of the W Series in 2021, which…
LONDON, UK – Leading print solutions provider, Corona Corporate Solutions (CCS), has acquired the Managed…
Manchester and Cheshire-based practice, Evolve Family Law, has chosen market-leading ‘Pay As You Go’ document…
Suwon, South Korea and Oslo, Norway, May, 5th 2021 – OliX Pharmaceuticals Inc. (KOSDAQ: 226950)…
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MAY 20201 at 11.00 EEST Orion Corporation: Managers’ transactions – Pia…
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MAY 2021 at 11.00 EEST Orion Corporation: Managers’ transactions – Kari…
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MAY 2021 at 11.00 EEST Orion Corporation: Managers’ transactions – Hilpi…
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MAY 2021 at 11.00 EEST Orion Corporation: Managers’ transactions – Eija…
Company announcement – No. 27/ 2021 Zealand Pharma Hosts Conference Call on May 12 at…
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MAY 2021 at 11.00 EEST Orion Corporation: Managers’ transactions – Mikael…
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MAY 2021 at 11.00 EEST Orion Corporation: Managers’ transactions – Timo…
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MAY 2021 at 11.00 EEST Orion Corporation: Managers’ transactions – Ari…
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MAY 2021 at 11.00 EEST Orion Corporation: Managers’ transactions – Veli-Matti…
Objective of this partnership with Takanawa Japan K.K., Pharma Team, is to identify a strategic…
Financial report for the period 1 January 2021 to 31 March 2021 Operating profit decreased…
Press Release Nicox partners with Laboratorios Grin to bring ZERVIATETM to Mexico May 5, 2021…
Tecentriq significantly improved overall survival in people with high PD-L1 expression, compared with chemotherapy in…
Strong cash and cash equivalents position at March 31, 2021 of CHF25.2M ($26.7M) Completed $11.5M…